To Bloc or Not to Bloc: Challenges in the Management of Patients Requesting En-Bloc Capsulectomy

摘要

Awareness of breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) coupled with increased public interest in the domain of breast implant illness have been key drivers in the evolving trend for patients to request implant removal. Much controversy surrounds the optimal management of implant capsules on removal or exchange.